DEXCOM INC Contracts & Agreements

Warrant Termination Agreement between DexCom, Inc. and Bank of America, N.A., dated February 13, 2024 (Filed With SEC on February 15, 2024)

Amended and Restated Collaboration and License Agreement, dated November 20, 2018, by and between DexCom, Inc. and Verily Life Sciences LLC (formerly Google Life Sciences LLC) (Filed With SEC on February 8, 2024)

Amended and Restated 2015 Equity Incentive Plan and forms of award agreements (Filed With SEC on February 8, 2024)

2015 Employee Stock Purchase Plan and forms of subscription agreements (Filed With SEC on February 8, 2024)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 8, 2024)

Amendment Number Thirteen to Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (Filed With SEC on October 26, 2023)

Amendment Number Sixteen to Amended and Restated Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and Byram Healthcare Centers, Inc (Filed With SEC on October 26, 2023)

Amendment Number Thirteen to Amended and Restated Non-Exclusive Distribution Agreement, dated June 1, 2023, by and between DexCom, Inc. and Byram Healthcare (Filed With SEC on July 27, 2023)

Amendment Number Twelve to Non-Exclusive Distribution Agreement, dated May 15, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (Filed With SEC on July 27, 2023)

Amendment Number Fourteen to Amended and Restated Non-Exclusive Distribution Agreement, dated April 1, 2023, by and between DexCom, Inc. and Byram Healthcare (Filed With SEC on July 27, 2023)

Amendment Number Eleven to Non-Exclusive Distribution Agreement, dated March 15, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (Filed With SEC on July 27, 2023)

DexCom, Inc. Amended and Restated Severance and Change in Control Plan effective June 1, 2017, and as amended on May 18, 2023 (Filed With SEC on May 19, 2023)

Indenture dated May 5, 2023 between DexCom, Inc. and U.S. Bank Trust Company, National Association (including the form of 0.375% Convertible Senior Notes due 2028) (Filed With SEC on May 5, 2023)

Amendment Number Nine to Non-Exclusive Wholesale Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (Filed With SEC on April 27, 2023)

Amendment Number Ten to Non-Exclusive Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (Filed With SEC on April 27, 2023)

Amendment Number Twelve to Amended and Restated Non-Exclusive Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and Byram Healthcare (Filed With SEC on April 27, 2023)

National Logistics Center / Brokerage Logistics Center Agreement dated June 1, 2022 between Cardinal Health and DexCom, Inc (Filed With SEC on July 28, 2022)

Redistribution Center (RDC) Agreement dated June 6, 2022 between McKesson Corporation and DexCom, Inc (Filed With SEC on July 28, 2022)

DexCom Incentive Bonus Plan (Filed With SEC on March 17, 2021)

Form of Subscription Agreement under 2015 Employee Stock Purchase Plan amended on December 13, 2019 (Filed With SEC on February 11, 2021)

Incentive Agreement between DexCom, Inc. and Jeffrey Moy dated April 28, 2020 (Filed With SEC on February 11, 2021)

Transition and Consulting Agreement between DexCom, Inc. and Richard B. Doubleday dated December 10, 2020 (Filed With SEC on February 11, 2021)

2015 Employee Stock Purchase Plan, amended on December 13, 2019 (Filed With SEC on February 11, 2021)

Form of Indemnity Agreement between Registrant and each of its directors and executive officers (Filed With SEC on February 11, 2021)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 11, 2021)

First Amendment to Amended and Restated Credit Agreement by and among DexCom, Inc., the Lenders, and JPMorgan Chase Bank as Administrative Agent, dated May 11, 2020 (Filed With SEC on July 28, 2020)

Indenture dated May 14, 2020 between DexCom, Inc. and U.S. Bank, National Association (Filed With SEC on May 15, 2020)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 13, 2020)

Fifth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated October 21, 2019 (Filed With SEC on February 13, 2020)

Form of RSU Grant Agreement 2015 Plan (Board Members - Annual Grant) (Filed With SEC on February 13, 2020)

Form of RSU Grant Agreement 2015 Plan (Board Members - Incoming Grant) (Filed With SEC on February 13, 2020)

Distribution Services Agreement dated November 7, 2015 between DexCom, Inc. and AmerisourceBergen Drug Corporation (Filed With SEC on February 13, 2020)

Amendment to the Distribution Services Agreement between Dexcom Inc. and AmerisourceBergen Drug Corporation (Filed With SEC on February 13, 2020)

Third Amendment to Office Lease between DexCom, Inc. and John Hancock Life Insurance Company, dated January 9, 2019 (Filed With SEC on February 13, 2020)

Fourth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated September 9, 2019 (Filed With SEC on February 13, 2020)

DexComs Executive Deferred Compensation Plan (Filed With SEC on June 4, 2019)

Amended and Restated Collaboration and License Agreement dated November 20, 2018 by and between DexCom, Inc., Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland... (Filed With SEC on February 21, 2019)

Amended and Restated Credit Agreement dated December 19, 2018 by and among DexCom, Inc., Bank of America, Silicon Valley Bank and Union Bank, and JPMorgan Chase Bank, as... (Filed With SEC on February 21, 2019)

Indenture dated November 30, 2018 between DexCom, Inc. and U.S. Bank National Association (Filed With SEC on December 3, 2018)

Form of RSU Grant Agreement 2015 Plan (Board Members - Incoming Grant) (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan Global Double Trigger (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan Global General (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan Global Single Trigger (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan Global (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan (Associates, Engineers, Managers, & Sr. Managers) (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan (Board Members - Annual Grant) (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan (Director Level Employees) (Filed With SEC on February 27, 2018)

Form of RSU Grant Agreement 2015 Plan (VP's and above) (Filed With SEC on February 27, 2018)

INDEMNITY AGREEMENT (Filed With SEC on August 1, 2017)

DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (March 16, 2017) (Filed With SEC on August 1, 2017)

FIRST AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on August 1, 2017)

PARTICIPATION AGREEMENT TO THE SEVERANCE AND CHANGE IN CONTROL PLAN (Filed With SEC on June 6, 2017)

SEVERANCE AND CHANGE IN CONTROL PLAN (Filed With SEC on June 6, 2017)

DEXCOM, INC. 0.75%CONVERTIBLE SENIOR NOTES DUE 2022 INDENTURE DATED AS OF MAY 12, 2017 U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE TABLE OF CONTENTS (Filed With SEC on May 12, 2017)

AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT between DEXCOM, INC. and VERILY LIFE SCIENCES LLC (FORMERLY GOOGLE LIFE SCIENCES LLC) (Filed With SEC on February 28, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on February 28, 2017)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 4, 2015)

DEXCOM, INC. 2015 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD GRANT NUMBER: (Filed With SEC on June 2, 2015)

SECOND AMENDMENT TO OFFICE LEASE (Filed With SEC on February 25, 2015)

[*****] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS AND ASTERISKS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on August 6, 2014)

Amendment Number Five to Non-Exclusive Distribution Agreement (Filed With SEC on August 6, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 1, 2014)

Amendment Number Three to Non-Exclusive Distribution Agreement (Filed With SEC on February 20, 2014)

NON-EXCLUSIVE DISTRIBUTION AGREEMENT between DEXCOM, INC. and Diabetes Specialty Center, LLC Dated Oct 12, 2009 (Filed With SEC on February 20, 2014)

Amendment Number Two to Non-Exclusive Distribution Agreement (Filed With SEC on May 1, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on February 21, 2013)

RESEARCH AND DEVELOPMENT AGREEMENT (Filed With SEC on February 23, 2012)

Exhibit A DEXCOM, INC. EXECUTIVE CHANGE OF CONTROL & SEVERANCE AGREEMENT (Filed With SEC on August 3, 2011)

Amendment No. 2 to the OUS Commercialization Agreement (Filed With SEC on August 3, 2011)

DexCom, Inc. 4,700,000 Shares Common Stock ($0.001 par value) Underwriting Agreement Underwriting Agreement (Filed With SEC on May 5, 2011)

DEXCOM INC. 2005 EQUITY INCENTIVE PLAN Approved by Stockholders on March 21, 2005 (and as amended thereafter) (Filed With SEC on May 3, 2011)

Amendment Number One to Non-Exclusive Distribution Agreement (Filed With SEC on May 3, 2011)

DexCom, Inc. 2,850,000 Shares Common Stock ($0.001 par value) Underwriting Agreement Underwriting Agreement (Filed With SEC on November 9, 2010)

FIRST AMENDMENT TO OFFICE LEASE (Filed With SEC on November 4, 2010)

DEXCOM INC. 2005 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD GRANT NUMBER: (Filed With SEC on May 5, 2010)

AMENDED AND RESTATED DEVELOPMENT, MANUFACTURING, LICENSING (Filed With SEC on March 9, 2010)

DexCom, Inc. 3,500,000 Shares (Filed With SEC on January 15, 2010)

AMENDMENT NO. 1 TO THE COMMERCIALIZATION AGREEMENTS (Filed With SEC on November 4, 2009)

LETTER OF AMENDMENT OF THE AMENDED AND RESTATED JOINT DEVELOPMENT AGREEMENT (Filed With SEC on November 4, 2009)

6340 Sequence Drive San Diego, CA 92121 ###-###-#### ###-###-####(fax) www.dexcom.com (Filed With SEC on August 3, 2009)

NON-EXCLUSIVE DISTRIBUTION AGREEMENT (Filed With SEC on August 3, 2009)

DEXCOM, INC. AMENDED AND RESTATED EXECUTIVE CHANGE OF CONTROL & SEVERANCE AGREEMENT (Filed With SEC on March 5, 2009)

15,994,000 Shares DEXCOM, INC. Common Stock PURCHASE AGREEMENT (Filed With SEC on January 30, 2009)

OUS COMMERCIALIZATION AGREEMENT (Filed With SEC on January 28, 2009)

AMENDED AND RESTATED JOINT DEVELOPMENT AGREEMENT (Filed With SEC on January 28, 2009)

COLLABORATION AGREEMENT BY AND BETWEEN (Filed With SEC on January 28, 2009)

CONFIDENTIAL TREATMENT REQUESTED MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on May 8, 2008)

Option Style: European Option Seller: Party A Option Buyer: Party B (Filed With SEC on March 12, 2007)

REGISTRATION RIGHTSAGREEMENT BY AND BETWEEN DEXCOM, INC., AS ISSUER AND PIPER JAFFRAY & CO. DATED AS OF MARCH 9, 2007 (Filed With SEC on March 12, 2007)

DEXCOM, INC., (Filed With SEC on March 12, 2007)

- Confidential - 5555 Oberlin Drive / San Diego, CA 92121 ###-###-#### /www.dexcom.com 1 (Filed With SEC on February 27, 2006)

Category

Industry

Companies

Contracts

DEXCOM INC Contracts & Agreements